510(k) Report

510(k) · Cleared

Cleared

IDS-iSYS Intact PTHN

K161158510(k) TraditionalCleared Jan 31, 2017281-day reviewClass II21 CFR 862.1545

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Immunodiagnostic Systems, Ltd. · CEW Radioimmunoassay, Parathyroid Hormone

Cleared on Jan 31, 2017 as substantially equivalent to K103325 (Immunodiagnostic Systems, Ltd., 2012) after a 281-day review. Its family tree reaches back 1 generation to 2012.

Decided
Jan 31, 2017
Review
281 days
Class
Class II
Product code
CEW
Recalls
None
Predicates
1

Its longest line of descent runs back 1 generation to K103325 (2012). No later device cites it as a predicate yet.

K103325 · Ids-Isys Intact PTH · Immunodiagnostic Systems, Ltd. · 201220102012201420162018
K103325 · Ids-Isys Intact PTH · Immunodiagnostic Systems, Ltd. · 20120
  1. Root · 1 generation backK103325 Ids-Isys Intact PTHImmunodiagnostic Systems, Ltd. · 2012
  2. This deviceK161158 IDS-iSYS Intact PTHNImmunodiagnostic Systems, Ltd. · 2017
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−1K103325Ids-Isys Intact PTHImmunodiagnostic Systems, Ltd.2012—
0 (this device)K161158IDS-iSYS Intact PTHNImmunodiagnostic Systems, Ltd.2017—
FIG. 1 — Lineage of K161158, 2012–2017Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in CEW? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new CEW device

  1. #1 K231927 Elecsys PTH , Elecsys PTH STATscore 7.6 · 3 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K103325Ids-Isys Intact PTH
Summary page 6
…w source of antibody for the assay. Page 2 of 10 9. Predicate Devices: IDS-iSYS Intact PTH, K103325 10. Special Conditions for Use: For in vitro diagnostic use. Rx Only 11. Special…
Immunodiagnostic Systems, Ltd.2012—

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • Its one ancestor has no recall.

How does its category compare?

All CEW devices

CEW Radioimmunoassay, Parathyroid Hormone: FDA decisions, review times, recalls and adverse event reports over 20 years. 2017, this device’s year, is highlighted.

FDA decisions per year · CEW

2in 2024

2007: 42010: 12012: 12013: 22014: 12015: 12017: 22019: 12023: 12024: 2
2007high 4 (2007) · low 0 (2008)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · CEW

160in 2007

2007: 160 days median
2007high 160 (2007)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · CEW

1in 2025

2007: 12008: 12010: 32013: 12016: 22022: 22024: 22025: 1
2007high 3 (2010) · low 0 (2009)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · CEW

37in 2025

2008: 82009: 42010: 232011: 972012: 1242013: 1722014: 1672015: 572016: 982017: 832018: 652019: 772020: 502021: 572022: 1882023: 822024: 672025: 37
2007high 188 (2022) · low 0 (2007)2025

MAUDE reports naming product code CEW, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
2007416010
20080—18
20090—04
20101—323
20110—097
20121—0124
20132—1172
20141—0167
20151—057
20160—298
20172—083
20180—065
20191—077
20200—050
20210—057
20220—2188
20231—082
20242—267
20250—137
20260—0—

What is it indicated for?

The IDS-iSYS Intact PTHN assay is an in vitro diagnostic device intended for the quantitative determination of intact PTH in human serum or plasma on the IDS-iSYS Multi-Discipline Automated System. Results are to be used in the differential diagnosis of hypercalcemia and hypocalcemia resulting from disorders of calcium metabolism.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K161158: IDS-iSYS Intact PTHN.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K161158

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026